Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
The Korean Journal of Internal Medicine
; : 256-276, 2018.
Article
en En
| WPRIM
| ID: wpr-713548
Biblioteca responsable:
WPRO
ABSTRACT
Hematopoietic stem cell transplantation (HSCT) is a treatment for hematologic malignancies, immune deficiencies, or genetic diseases, ect. Recently, the number of HSCTs performed in Korea has increased and the outcomes have improved. However, infectious complications account for most of the morbidity and mortality after HSCT. Post-HSCT infectious complications are usually classified according to the time after HSCT pre-engraftment, immediate post-engraftment, and late post-engraftment period. In addition, the types and risk factors of infectious complications differ according to the stem cell source, donor type, conditioning intensity, region, prophylaxis strategy, and comorbidities, such as graft-versushost disease and invasive fungal infection. In this review, we summarize infectious complications after HSCT, focusing on the Korean perspectives.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Células Madre
/
Donantes de Tejidos
/
Infecciones Oportunistas
/
Células Madre Hematopoyéticas
/
Comorbilidad
/
Enfermedades Transmisibles
/
Factores de Riesgo
/
Mortalidad
/
Huésped Inmunocomprometido
/
Trasplante de Células Madre Hematopoyéticas
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Humans
País/Región como asunto:
Asia
Idioma:
En
Revista:
The Korean Journal of Internal Medicine
Año:
2018
Tipo del documento:
Article